Steffan T. Nawrocki, Ph.D.
Affiliations: | 2005 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Cell Biology, Oncology, PharmacologyGoogle:
"Steffan Nawrocki"Parents
Sign in to add mentor| David J. McConkey | grad student | 2005 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
| (Induction of endoplasmic reticular stress by bortezomib: A novel therapeutic strategy for pancreatic cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jones TM, Espitia CM, Chipollini J, et al. (2023) Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity. Cancer Research Communications. 3: 245-257 |
| Jones TM, Espitia CM, Ooi A, et al. (2022) Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism. Cell Death & Disease. 13: 350 |
| Islam S, Espitia CM, Persky DO, et al. (2021) Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma. Viruses. 13 |
| Islam S, Espitia CM, Persky DO, et al. (2021) Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma Viruses. 13: 1406 |
| Islam S, Espitia CM, Persky DO, et al. (2020) Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy. Blood Advances. 4: 5297-5310 |
| Nawrocki ST, Wang W, Carew JS. (2020) Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance. Cancers. 12 |
| Usman RM, Razzaq F, Akbar A, et al. (2020) Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance. Asia-Pacific Journal of Clinical Oncology |
| Jones TM, Carew JS, Nawrocki ST. (2020) Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy. Cancers. 12 |
| Kathawala RJ, Espitia CM, Jones TM, et al. (2020) ABCG2 Overexpression Contributes to Pevonedistat Resistance. Cancers. 12 |
| Jones T, Espitia C, Carew J, et al. (2020) Abstract 5211: Targeting Neddylation synergistically augments the activity of cisplatin in head and neck cancer models to yield long-term survival by modulating key DNA damage and redox pathways Cancer Research. 80: 5211-5211 |